# FDA Approves Teva Pharmaceuticals Generic Drug Application Teva Pharmaceuticals USA Inc. received FDA approval for ANDA 211583 on April 6, 2026, potentially expanding its generic portfolio and strengthening its position in the competitive biosimilar and generic markets. The approval could enable Teva to capture additional market share and provide cost-effective therapeutic alternatives to healthcare systems seeking to reduce medication expenses.